SLOW RELEASE NALTREXONE IMPLANT VS ORAL NALTREXONE FOR IMPROVING TREATMENT OUTCOMES IN OPIOID ADDICTED PATIENTS WITH HIV: A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL

2020 ◽  
pp. 5-30
Author(s):  
E.M. Krupitsky ◽  
E.A. Blokhina ◽  
E.E. Zvartau ◽  
E.V. Verbitskaya ◽  
D.A. Lioznov ◽  
...  
Keyword(s):  
Randomized Trial ◽  
Treatment Outcomes ◽  
Slow Release ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Oral Naltrexone

Intravenous fosaprepitant for the prevention of chemotherapy-induced vomiting in children: A double-blind, placebo-controlled, phase III randomized trial

2018 ◽  
Vol 66 (3) ◽  
pp. e27551 ◽  
Author(s):  
Venkatraman Radhakrishnan ◽  
Archit Joshi ◽  
Jaikumar Ramamoorthy ◽  
Swaminathan Rajaraman ◽  
Prasanth Ganesan ◽  
...  
Keyword(s):  
Randomized Trial ◽  
Phase Iii ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document